Status:

UNKNOWN

Ketamine for Thrombolysis in Acute Ischemic Stroke

Lead Sponsor:

University Hospital, Caen

Collaborating Sponsors:

Société Française d'Anesthésie Réanimation

Fondation NRJ

Conditions:

Stroke

Eligibility:

All Genders

18-85 years

Phase:

PHASE1

PHASE2

Brief Summary

KETA trial is a nonprofit, double-blind, randomized, controlled pilot trial with aiming to determine if co-administration of ketamine with recombinant of tissue type plasminogen activator (tPA) for th...

Detailed Description

Rationale - Tissue-type plasminogen activator (tPA) is a double-sided molecule, with beneficial effect in acute ischemic stroke due to its intravascular fibrinolytic activity but with potential delete...

Eligibility Criteria

Inclusion

  • Sudden focal neurological deficit attributable to acute ischemic stroke.
  • Age between 18 and 85.
  • Time from symptom onset less than 4.5 hours.
  • NIHSS score between 7 and 20.
  • Informed consent for participation.
  • Ketamine can be administered within 15 minutes after onset of tPA infusion.
  • MRI-based AIS diagnosis.
  • Middle cerebral (M1 or M2 segment) and/or distal internal carotid artery occlusion.
  • No intracranial hemorrhage on MRI.
  • Patient eligible for thrombectomy.

Exclusion

  • Contraindication to IV tPA treatment.
  • Contraindication to ketamine.
  • Contraindication to MRI.
  • Contraindication to intravascular iodinated contrast media.
  • Consciousness level \>1 on question 1a of NIHSS.
  • Pre-stroke mRS ≥3.
  • Concomitant medical illness that would interfere with outcome assessments and follow-up (e.g. advanced cancer or respiratory disease).
  • Previous participation in this trial or current participation in another investigational drug trial.
  • Infarct volume on diffusion weighted MRI more than 100 mL.

Key Trial Info

Start Date :

March 1 2015

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

February 1 2018

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT02258204

Start Date

March 1 2015

End Date

February 1 2018

Last Update

February 24 2016

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

CHU Caen

Caen, France